IFN-Stimulated Gene 15 Is Synergistically Activated Through
T ype I IFNs (␣ or ␤) confer an antiviral state, affect cell growth and differentiation, and modulate the immune system. Type I IFNs initiate a signaling cascade that results in the induction of a subset of genes termed IFN-stimulated genes (ISGs). 4 This induction is mediated by a specific DNA binding elements designated IFN-stimulated response elements (ISREs), which are located at their promoters (1) . The ISRE element serves as the binding site for a family of transcription factors termed IFN regulatory factors (IRFs). Nine cellular IRFs that execute part of the effects of IFN have been identified to date. Some of the IRFs, such as IRF-1, IRF-2, IRF-3, and IRF-7, bind directly to ISRE elements, while others, such as IRF-4 and IRF-8/IFN consensus sequence binding protein (ICSBP), do not bind effectively to the ISRE element alone (for review, see Ref. 2) . However, IRF-8\ICSBP can associate with either IRF-1 or IRF-2, forming heterocomplexes that bind efficiently to the DNA (3, 4) . Further, both IRF-4 and IRF-8\ICSBP also associate with non-IRF members such as PU.1 or E47 on a DNA composite element, half of which is an IRF binding site and half of which is the binding site of the interacting partner (5, 6) . These protein-protein interactions are mediated through a conserved domain termed the IRF association domain (IAD) (7) . The IAD motif was found in all seven IRFs, excluding IRF-1 and IRF-2, which associate with IRF-8\ICSBP. In contrast, a domain rich in Pro, Glu, Ser, and Thr (PEST) mediates the interaction of PU.1,E47, IRF-1, and IRF-2 with IRF-8\ICSBP. Further, the IAD and the PEST domains also mediate the interactions between IRF-4 and PU.1 or E47 (6 -8) .
The expression of both IRF-4 and IRF-8\ICSBP is limited to immune cells (5, 9 -11) . Studies with knockout mice demonstrated that IRF-4 plays a crucial role in controlling the activation and homeostasis of immune responses and is critical for proper maturation of B cells (12) . IRF-8\ICSBP is essential for myeloid cell differentiation toward mature macrophages (13) . Both IRFs possess a dual role in lymphoid cells; binding to ISRE elements leads to a repression of ISG expression, while interaction with lymphoid/ myeloid essential transcription factors (PU.1 and E47) leads to transcriptional activation (5, 9 -11) . PU.1 is predominately expressed in cells of the hemopoietic lineage and is a critical regulator of myeloid/lymphocyte differentiation. PU.1 can bind alone to a core motif (A/GGAA) that is shared by most ETS proteins (14) ; however, additional flanking sequences define the ultimate binding specificity: for example, the ETS/IRF composite element (EICE) to which IRF-4 and IRF-8\ICSBP bind following interaction with PU.1. Such composite DNA motifs were identified in numerous genes essential for proper macrophage and B cells function (15) .
The ISG15 gene, which contains ISRE element in its promoter, is one of the most strongly induced proteins in cells following IFN type I treatment or viral infection (16 -18) . Deletion or mutations in this ISRE element lead to the inability to respond to these signals (16) . ISG15 is a 17-kDa ubiquitin-like protein produced as a precursor protein. Correct processing is essential for its conjugation to cellular target and for its extracellular cytokine function (19, 20) . ISG15 is secreted from monocytes, and the secreted form leads to NK proliferation and augmentation of non-MHC-restricted cytotoxicity. Thus, ISG15 may be considered a cytokine responsible for augmenting and amplifying the immunomodulatory effects of IFN-␣ or IFN-␤.
Here we show that ISG15 contains a unique ISRE element that enables the binding not only of IRFs, but also of PU.1. This ISRE represents a subtype of ISREs that, in addition to IRFs, recruits PU.1. This composite ISRE element is synergistically activated by a heterocomplex formed between PU.1 and either IRF-8\ICSBP or IRF-4. These interactions lead to specific regulation of ISG15 in immune cells, laying the molecular basis for its unique role in these cells.
Materials and Methods

Cell culture
NIH-3T3, U937, Namalwa, and K562 cells were obtained from American Type Culture Collection (Manassas, VA). NIH-3T3 were maintained in DMEM, while the other cell lines were maintained in RPMI 1640. All media were supplemented with 10% FCS, except for Namalwa cells, which were supplemented with 7.5% FCS.
Plasmids
Mammalian expression vectors, which are also suitable for in vitro transcription (IVT), corresponding to IRF-1, IRF-4, PU.1, IRF-8\ICSBP, ICSBPL331P, and ICSBPS260A, were previously described (7, 21) .
The plasmids pCB6PU.1⌬PEST and pCB6PU.1S148A were obtained from Dr. M. Atchison (University of Pennsylvania, Philadelphia, PA) (22) . Site-directed mutagenesis of tyrosine residues Y23 and Y48 within the DNA binding domain (DBD) of IRF-8\ICSBP (ICSBPY23F and ICSBPY48F) to phenylalanine were generated using the plasmid pTarget-ICSBP (7) and the GeneEditor kit (Promega, Madison, WI) with the primers Y23F (5Ј-GACAGTAGCATGTTTCCAGGCCTGATTTGGG-3Ј) and Y48F (5Ј-GGAAACACGCCGGCAAGCAAGATTTTAAT-3Ј).
The plasmid p(ISRE) 4 -LUC, obtained from Dr. K. Ozato (National Institutes of Health, Bethesda, MD), is a reporter gene plasmid in which the luciferase gene (firefly) is driven by the thymidine kinase basal promoter connected to four repeats of the ISG15-ISRE in the basic plasmid pBL-2 (Promega). In the plasmid p1.4L d -LUC, 1.4 kb of the promoter region of the L d gene from the murine MHC class I is driving the luciferase (firefly) reporter gene (obtained from Dr. K. Ozato, National Institutes of Health). To monitor transfection efficiency, a dual luciferase reporter assay was used with the plasmid pMDISRluc, in which the SV40 promoter drives the expression of Renilla luciferase.
DNA transfections and reporter gene analyses
NIH-3T3 cells were transfected by the calcium phosphate-DNA coprecipitation method as described previously (7, 23) . Cells were plated in a sixwell dish and transfected with 400 ng to 1 g of the various expression plasmids and reporter plasmids (firefly luciferase), 600 ng pMDISRluc (SV40 promoter driving the expression of Renilla luciferase to monitor transfection efficiencies), and pUC19 serving as carrier DNA up to total of 3 g. The expression plasmids coding for the various transcription factors and reporter genes are indicated in the text. The cells were harvested 48 h later and lysed using the lysis buffer with the Dual Luciferase assay kit (Promega), and luciferase activities were determined according to the manufacturer's instructions using a TD-20/20 luminometer (Turner Design; Promega). Reporter gene activities were normalized for protein concentration and transfection efficiencies as previously described (24) . Western blot analyses were performed with each transfected expression vector to ensure the expected level of ectopic protein expression (data not shown). Each set of transfection experiments was repeated at least three times, generating similar results.
U937 cells were diluted to 10 6 cells/ml 16 -24 h before transfection. At the time of transfection the cells were washed twice in PBS and suspended at 2.5 ϫ 10 7 cells/ml in RPMI medium lacking FCS and antibiotics. Part (0.4 ml) of the cell suspension was placed into a 0.4-cm electroporation cuvette (Bio-Rad, Richmond, CA), and up to 30 g plasmid DNA suspended in Յ20 l distilled water was added. Cells and plasmids DNA were incubated for 10 min at room temperature before electroporation at 500 F and 300 V (Bio-Rad gene pulser). Following the electric shock the cells were left at room temperature for an additional 15 min and then diluted into 10 ml RPMI containing 10% FCS. Forty-eight hours after electroporation the cells were harvested and analyzed as described above for NIH-3T3 cells.
In vitro transcription and translation
The assays were performed as described previously (7) . Plasmids containing the gene of interest under the T7 promoter were linearized downstream of the coding region with the appropriate restriction enzyme. Five micrograms of linearized plasmids were in vitro transcribed by T7 RNA polymerase using a commercial kit (Stratagene, La Jolla, CA). Proteins were translated in vitro using the rabbit reticulocyte lysate system (Promega) according to the manufacturer's instructions. To monitor translation efficiency, small scale reactions containing [ 35 S]methionine were performed each time, and the labeled proteins were separated on 10% SDS-PAGE and subjected to autoradiography.
EMSA
Nuclear extracts and gel-shift reactions were conducted as previously described (24, 25) . A typical reaction contained 1-5 l IVT proteins or 5-8 g nuclear extracts that were incubated in binding buffer (10 mM HEPES (pH 8), 5 mM MgCl 2 , 50 mM KCl, 0.025% bromophenol blue, 0.005% xylene cyanole, 10% Ficoll, 3% glycerol, and 1 g sonicated polyd(IC)) for 20 min. One microgram of sheared salmon sperm DNA was added only with IVT proteins. At least 50,000 cpm of the labeled probe (ISG15-ISRE) was added for an additional 10 min on ice. The two synthetic oligonucleotides corresponding to the ISG15-ISRE (5Ј-GATCCTCGGGAAAGG GAAACCGAAACTGAAGCC-3Ј) were annealed and labeled with Klenow fragment. The samples were loaded on a pre-run 6.5% polyacrylamide gel. The dried gels were exposed to x-ray films. For supershift reaction, 1-2 l Abs was added, and the reactions were incubated for 60 -90 min on ice before addition of the labeled probe. Abs directed against PU.1 were purchased from BD PharMingen (San Diego, CA), and Abs against IRF-4 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Antipeptide Abs against IRF-8\ICSBP (anti-pepC) were obtained from Dr. K. Ozato. Antipeptide Abs against IRF-1 (pep300) and IRF-2 (pep311) were previously described (26) .
Results
Both IRF-8\ICSBP and IRF-4 inhibit IRF-1-mediated transcriptional activation of ISG15-IRES
ISGs are regulated by type I IFNs through the binding of IRFs to the ISRE located at their promoter region. IRF-1 is a prototype IRF, which transcriptionally activates such promoters. We have previously shown that IRF-8\ICSBP can associate with IRF-1, and this association leads to repression of IRF-1 action on either the ISRE of MHC class I or the positive regulatory domain I (PRDI) element (a core sequence of ISRE) located on the promoter of IFN-␤ (24, 27) . Here we show that the same effect of IRF-8\ICSBP on IRF-1 also takes place on the ISRE element of ISG15. Fig. 1A shows that IRF-1 can activate the expression of a reporter gene driven by four ISRE repeats from the promoter of ISG15 (Fig. 1A,  lane 2) . Cotransfection of IRF-8\ICSBP leads to repression (Fig.  1A, lane 8) . Previously, we have shown that this repression is mediated through association between IRF-1 and the IAD module of IRF-8\ICSBP. This was demonstrated by mutating the conserved leucine 331, which is located in the IAD in a predicted ␣-helix structure to proline. This point mutation interferes with this structured domain, leading to a mutant IRF-8\ICSBP incapable of interacting with other factors (7). It is clear from Fig. 1A that this mutation also affects the ability of IRF-8\ICSBP to repress IRF-1 on the ISG15-ISRE element (Fig. 1A , compare lane 9 to lane 2). Further, we have also shown that serine 260 in IRF-8\ICSBP is essential for protein-protein interaction (21) . Similar results are demonstrated here; mutation of this serine residue within the IAD of IRF-8\ICSBP eliminates its ability to negate IRF-1 (Fig. 1A , lane 10). In contrast, mutating tyrosine residues within the DBD of IRF-8\ICSBP to phenylalanine (Y48F and Y23F) have no effect on the repression activity of IRF-8\ICSBP (Fig. 1A, lanes 11 and 12,  respectively) . Fig. 1B shows that unlike IRF-8\ICSBP, IRF-4 elicits weak transcriptional activation on a reporter gene driven by ISG15-ISRE (Fig. 1B, lane 3) . Cotransfection of IRF-1 and IRF-4 at equimolar levels does not lead to synergistic repression, but, rather, to a midlevel expression, which is probably a result of co-occupancy of the ISRE elements by both IRF-1 and IRF-4 (Fig. 1B, lane 4) . Cotransfection of IRF-1 with IRF-8\ICSBP and IRF-4 leads to an additional decrease in the reporter gene level (Fig. 1B, lane 5) . These results are further supported by EMSA, as shown in Fig. 1C . It is clear that unlike IRF-1, neither IRF-8\ICSBP nor IRF-4 binds to the ISRE element alone (Fig. 1C, lanes 2, 4 , and 5, respectively). Yet IRF-1 and ICSBP form a heterocomplex (Fig. 1C, lane 3 ) that was supershifted with Abs directed against each of the interacting factors (data not shown). In contrast, no heterocomplex band was observed for IRF-1 and IRF-4 or IRF-8\ICSBP and IRF-4 ( Fig. 1C , lanes 6 and 7, respectively). The same phenomenon was also observed with IRF-2 (data not shown). These results are consistent with our previous data showing that only IRF-8\ICSBP can interact with either IRF-1 or IRF-2, and this interaction leads to synergistic repression (7, 24) . Such an effect was not detected with IRF-4.
PU.1 and either IRF-8\ICSBP or IRF-4 elicit synergistic activation of ISG15-ISRE
The ISG15 expression is dysregulated in macrophages from IRF-8ICSBP knockout mice, demonstrating its unique role in these cells (28) . This prompted us to determine whether this dysregulated expression can be attributed to lack of heterocomplex formation between PU.1 and IRF-8\ICSBP, which are both essential for myeloid cell differentiation (14) . To test this possibility, transient transfection studies were performed with PU.1, IRF-8\ICSBP and their mutants (Fig. 2) . Cotransfection of IRF-8\ICSBP and PU.1 leads to the activation of a reporter gene driven by the ISG15-ISRE (Fig. 2A, compare lanes 2 and 3 to lane 8) . These results are in contrast to the results observed with IRF-1 (Fig. 1) . This activation is dependent on protein-protein interaction, because cotransfection of mutant IRF-8\ICSBP expression constructs defective in the IAD (mutation of the conserved leucine 331 or the nonconserved serine 260) leads to elimination of this transcriptional synergy (Fig. 2A, compare lane 8 to lanes 9 and 10) . In addition, this interaction is dependent on the presence of tyrosine residues 23 and 48 in IRF-8\ICSBP, which are conserved in IRF-4. Mutating these residues to phenylalanine diminished the synergistic activity with PU.1 ( Fig. 2A, lanes 11 and 12) . It is possible that the phosphorylation state of these residues is essential for the interaction with only PU.1, because these mutations on tyrosine residues had no effect on the interaction with IRF-1 ( Fig. 1) and IRF-2 (data not shown). This suggests that the interaction of PU.1 with IRF-8\ICSBP is dependent upon its intact IAD as well as DBD. Synergistic activation of the ISG15-driven reporter gene by IRF-8ICSBP and PU.1 was also observed with the promonocytic cell line U937, which constitutively expresses these two factors (data not shown). To avoid endogenous background expression of these genes, which may interfere with the ectopic expression, additional experiments were performed with NIH-3T3 cells, which do not express these genes.
Previous studies demonstrated that association of PU.1 with either IRF-4 or IRF-8\ICSBP is mediated through a PEST domain, and the phosphorylation of serine 148 is crucial for this association (6 -8) . The data in Fig. 2B clearly show that the synergistic effect of PU.1 and IRF-8\ICSBP on the ISRE of ISG15 is lost when either serine 148 is mutated to alanine or the whole PEST domain is deleted (Fig. 2B, compare lanes 6, 7, and 8, respectively) .
IRF-4 was the first IRF member that demonstrated transcriptional synergy with PU.1 on EICE. Therefore, we tested whether such a synergistic effect also takes place on the classical ISRE element of ISG15. The data in Fig. 2C clearly show a synergistic effect of PU.1 and IRF-4 on the expression of an ISRE-driven reporter gene (Fig. 2C, lane 5) . This synergistic effect is also dependent upon intact IRF-4-IAD, because mutation of the conserved leucine 386 to proline (corresponding to leucine 331 in IRF-8\ICSBP), which interferes with the predicted ␣-helix structure, also results in a lack of synergistic activity of this mutant IRF-4 with PU.1 (Fig. 2C, lane 6) .
To determine whether the synergistic effect between PU.1 and IRF-8\ICSBP or IRF-4 is unique to the ISRE of ISG15, we also tested the MHC class I promoter containing characterized ISRE and the PRDI element from the IFN-␤ promoter (10, 27) . No synergistic effect between PU.1 and IRF-8\ICSBP was observed on a luciferase reporter gene driven by either MHC class I ISRE (Fig.  2D) or the PRDI element of IFN-␤ (data not shown). These results suggest that the observed synergistic activity of PU.1 is not common to all ISREs.
The ISRE of ISG15 supports association between PU.1 and either IRF-8\ICSBP or IRF-4
The above data demonstrate that the ISRE of ISG15 is synergistically activated by PU.1 and either IRF-8\ICSBP or IRF-4. To demonstrate the physical interaction between these factors, EMSA was performed. PU.1 as well as IRF-8\ICSBP and various mutants of IRF-8\ICSBP were in vitro-translated and reacted with the labeled ISRE element of ISG15. Neither PU.1 nor IRF-8\ICSBP binding to this ISRE element could be detected in this assay (Fig.  3A, lanes 2 and 3, respectively) . However, when the two proteins were mixed together a new band corresponding to the heterocomplex band was observed (Fig. 3A, lane 4) . This heterocomplex band was supershifted with Abs directed against IRF-8\ICSBP and was eliminated by Abs against PU.1 (data not shown). This interaction was dependent upon intact IRF-8\ICSBP-IAD, because the mutations in leucine 331 to proline and serine 260 to alanine lead to either loss of the heterocomplex band (Fig. 3A, lane 11, for  ICSBPL331P ) or a significant reduction in its intensity (Fig. 3A,  lane 10, for ICSBPS260A) . The EMSA results with ICSBP-IAD are in agreement with the cotransfection studies, which demonstrated that these mutants lost their ability to synergize with PU.1 (Fig. 2) . We also tested mutants of ICSBP in tyrosine residues within the DBD, which are conserved in IRF-4 (Y23F and Y48F). It is clear that mutation at tyrosine 48 lead to reduced interaction as demonstrated by a weaker heterocomplex band, while mutation at tyrosine 23 leads to increased interaction (Fig. 3A, lanes 8 and  6, respectively) . 4-LUC) was analyzed as described in Fig. 1, A and B. FIGURE 2. The synergistic activation of ISG15-ISRE by PU.1, IRF-8ICSBP, and IRF-4 is dependent upon intact IAD and PEST domains. NIH-3T3 cells were transfected as described in Fig. 1, A and B , with the indicted expression plasmids. The luciferase activity of the reporter gene alone was normalized to a value of 1, and relative luciferase activities of the various transfections were calculated accordingly as fold activation relative to this value. The experiments were repeated four times with similar results. Error bars denote the SD. A, The ability of PU.1 and either IRF-8\ICSBP or mutated constructs of IRF-8\ICSBP to activate p(ISRE) 4 -mutant (Fig. 3B, lane 4) . Further, no heterocomplex was detected when IRF-8\ICSBP and IRF-4 were reacted with the ISRE of ISG15 (Fig. 3B, lane 5) . Interestingly, when all three proteins were mixed together, a much stronger heterocomplex band was observed (Fig. 3B, lane 6 ). This suggests that the heterocomplex might be composed of all three components (PU.1, IRF-8\ICSBP, and IRF-4) in an unknown stoichiometry.
No heterocomplex bands were observed with PU.1, IRF-8ICSBP, and IRF-4 when the ISRE of MHC class I or the PRDI element of IFN-␤ was used as a probe in the EMSA (data not shown).
Interaction between PU.1 and either IRF-8\ICSBP and/or IRF-4 is also detected in hemopoietic cells
We next wanted to determine whether heterocomplexes between PU.1 and either IRF-8\ICSBP and IRF-4 also occur in vivo. For that purpose, nuclear extracts were prepared from the promonocytic cell line U937 and the B lymphocyte cell line Namalwa, which both constitutively express all three factors. In addition, nuclear extract was prepared from the erythroleukemia cell line K-562, which expresses PU.1, but does not express IRF-8\ICSBP or IRF-4. Five major bands (I, II, II, IRF-2, and PU.1) were observed in EMSA using labeled ISRE from ISG15 and U937 cell extract (Fig. 4, upper panel) . Abs against either PU.1 or IRF-2 enabled us to detect the bands corresponding to the binding of only these factors compared with cell extract reacted with preimmune serum (Fig. 4, upper panel, lanes 3, 5, and 1, respectively) . In addition, these two Abs led to a reduction in the intensity of all the three upper bands (I, II, and III). However, the decrease in the intensity of band II was most prominent. This suggested that the band marked as II might represent the major heterocomplex bands between PU.1 and either IRF-8\ICSBP and IRF-4 or the heterocomplex band between IRF-2 and only IRF-8\ICSBP. Accordingly, the addition of Abs directed against IRF-8\ICSBP and IRF-4 mainly eliminated this band (band II, Fig. 4, upper panel, lanes 2 and 4, respectively) . Abs against IRF-2, IRF-8\ICSBP, and IRF-4 led to the appearance of a shifted band, while Abs directed against PU.1 resulted in band elimination (Fig. 4, upper panel, compare lanes 2, 4, and 5 to lane 3) . In contrast, Abs directed against IRF-1 did not lead to any change in the band pattern compared with that in the control (Fig. 4, upper panel, compare lane 6 to lane 1), but, rather, led to a stronger signal. Similar results were observed with Namalwa cell extract (Fig. 4 , middle panel). When K562 cell extract, which does not express IRF-8\ICSBP and IRF-4, was used, there was no effect on the bands pattern with Abs against IRF-8\ICSBP, IRF-4, PU.1, and IRF-1. A supershifted band is clearly seen with Abs directed against IRF-2, resulting in a significant reduction in the intensity of band II. Altogether these results demonstrate that all the factors, PU.1, IRF-8\ICSBP, IRF-4, and IRF-2 (with the exception of IRF-1), interact with the ISRE of ISG15. These interactions are dependent upon the composition of transcription factors in the cells, because such interactions were not observed in K562 cell extract.
Our data suggest that the classical ISRE element of ISG15 can be engaged not only through the direct binding of some IRF members or through the interaction between IRF-8\ICSBP and either IRF-1 or IRF-2 (Fig. 1C) , but also through interactions with non-IRF members, e.g., PU.1. The core motif for PU.1 DNA binding is GGAA (29) , and the ISRE of ISG15 contains two GGAA motifs. To define the region essential for the interaction observed in U937 cells, five mutant oligonucleotides (illustrated in Fig. 5A ) were synthesized and used as competitors in the EMSA. It is clear that the M1 oligonucleotide, in which the 5Ј-positioned GGAA motif was mutated, competed for the binding as well as the wild-type oligonucleotide (Fig. 5B, compare lanes 2 and 3 to lane 1) . In contrast, the M2 oligonucleotide, in which the 3Ј-positioned GGAA motif was mutated, did not compete for the binding (Fig.  5B, lane 4) . Like the M2 oligonucleotide, the M5 oligonucleotide, in which both putative PU.1 binding sites were mutated, did not elicit any competition. This suggests that the 3Ј-positioned GGAA motif, which is closer to the IRF binding site, is essential for protein-protein interaction. The M3 and the M4 oligonucleotides were mutated in the two possible IRF binding sites, ACCGAAA and ACTGAA. The data show that only partial competition was achieved with each oligonucleotide, suggesting that both are essential for IRF binding.
To complement these competition experiments, each mutant oligonucleotide was labeled and used as a probe in EMSA, and the band pattern was compared with the band pattern seen with the labeled ISG15-ISRE oligonucleotide. The data summarized in Table I demonstrate that the M2 mutant had the strongest effect on PU.1 binding and the interaction with IRF-8\ICSBP and IRF-4 (similar to the pattern seen with M5). Further, when M4 was used as a probe, no heterocomplex band with IRF-8\ICSBP and IRF-4 was observed, although the binding of IRF-2 was still detectable. These experiments show that the 3Ј-positioned GGAA and the 3Ј IRF binding site (AACTGA) are essential for the formation of heterocomplexes between PU.1 and either IRF-8\ICSBP or IRF-4 on the ISRE element of ISG15. Both IRF binding sites were able to recruit IRF-2, because its binding was not lost with any of the mutant oligonucleotides. Taken together our data suggest that the ISG15-ISRE allows not only the binding of IRF members, but also the binding of PU.1, and should be considered a DNA composite element.
Discussion
Exposure of cells to IFN type I leads to the induction of many genes. Friedman and Stark (30) were the first to note that these genes are characterized by a specific DNA motif at their promoter region, which they termed IFN consensus sequence. This DNA motif was further characterized, and the core region was refined and renamed ISRE (31) . The ISRE of ISG15 is considered a prototypic element that is regulated through the binding of various IRFs. The ability of IRF-1, IRF-3, and IRF-9/ISGF3␥ (in the context of ISGF3) to bind this element was demonstrated by EMSA, and the effect on transcriptional regulation was shown in many cell types and tissues (16, 32, 33) . Further, while using this ISRE it was shown that both IRF-1 and IRF-2 can associate with IRF-8\ICSBP to form heterocomplexes, and these complexes possess repression activity in immune cells (3, 4) .
In this communication we provide evidence that the ISRE of ISG15 is synergistically activated by the myeloid/lymphocyte-restricted factors PU.1 and either IRF-8\ICSBP or IRF-4. This synergistic activity is further supported by the EMSA results showing that heterocomplexes between these factors are detectable with in vitro-translated proteins or in nuclear extract from cell lines of monocytic and lymphocytic origin. These results demonstrate that this ISG15-ISRE element is able to recruit not only IRFs, but also a non-IRF member such as PU.1, which belong to the ETS family of transcription factors. Interaction among IRF-8\ICSBP, IRF-4, and PU.1 was reported for numerous enhancer elements in many genes that are essential for proper biological activities of either macrophages or B cells. These interactions occur on EICE, which were identified on enhancer elements of Ig L chain, CD20, IL-1␤, Toll-like receptor 4, and more (for review, see Ref. 15) . This is consistent with the restricted expression of these factors in cells of myelocyte/lymphocyte origin. Our results clearly show that the classical ISG15-ISRE can also recruit PU.1 and therefore can also be defined as EICE. Sequence alignment of numerous ISRE elements displayed in Table II clearly shows that classical ISREs can be divided into two categories. The first category (subtype) consists of ISRE elements that recruit only IRFs (Table II , upper section). The lower part of Table II shows classical EICE elements in which the PU.1 binding site (GGAA) is shaded, and the IRF binding site is in the boxed area adjacent to the PU.1 element. The middle part of Table II 
a EMSAs were performed with U937 cell extracts, which were reacted with 32 Plabeled ISG15-ISRE oligonucleotide or mutant oligonucleotide as indicated in the presence of Abs as described in Fig. 4 results were obtained with regulatory elements from CYBB and NCF2 genes, which encode for the phagocyte respiratory burst oxidase subunits gp91 phox and p67 phox , respectively. These results suggest that the CYBB and NCF2 enhancer elements are EIRE and as such can be engaged by IRFs heterocomplexes as well as PU.1IRFs heterocomplexes as reported recently (34) .
The ability of the EIRE DNA motifs to recruit not only IRFs, but also PU.1/IRF heterocomplexes, suggests that some of the genes harboring such elements might be regulated differentially in immune cells. Consequently, some of the genes listed in Table II as harboring EIREs also possess a unique role in immune cells. For example, the induced expression of ISG15 by type I IFNs in many cell types and tissues is well documented. However, ISG15 is also secreted from monocytes and lymphocytes and modulates the immune system. Its ability to activate NK cells is dependent on cocultivation with T cells (19) . Similarly, the induced expression of the IFN-induced and dsRNA-activated kinase (PKR) in many cell types and tissues, resulting in antiviral and antiproliferative effects, is well established (35) . Yet, recent studies also implicated PKR in the growth control of mature T lymphocytes (36) . IFN-inducible protein 10 is induced and secreted by many cell types. Costimulation of macrophages by LPS and IFN-␥ leads to its expression and subsequent effect on Th1 cells harboring the target receptor, CXCR3 (37) . The 9 -27 gene is also a prototypic ISG that is expressed in many cell types as a cell surface protein. However, it has a unique role in B cells, being a component of a larger B cell CD81 complex involved in signal transduction and cell adhesion (38) .
The fact that these EIRE elements can recruit IRF-8\ICSBP or IRF-4 suggests that these elements will respond not only to IFN type I, but also to IFN-␥, which leads to transcriptional induction of IRF-8\ICSBP and to antigenic stimulation resulting in the induction of both IRF-8\ICSBP and IRF-4. Hence, PKR, IFN-inducible protein 10, 9 -27, CYBB, and NCF2 are also induced by IFN-␥ or antigenic stimulation or both (34, 36 -38) .
We show that the interaction of PU.1 with either IRF-8\ICSBP or IRF-4 is dependent upon intact interaction modules, e.g., PEST and IAD, respectively. Our data also show that serine 260, which is unique to the IAD of IRF-8\ICSBP, is essential for this interaction, suggesting that the phosphorylation state of this residue is essential (for more details see Ref. 21 ). Tyrosine phosphorylation is also essential for proper activity of IRF-8\ICSBP. Specific tyrosine phosphorylation prevents ICSBP from binding alone to target DNA; nevertheless, this phosphorylation is essential for efficient protein-protein interaction (24) . Here we show that mainly tyrosine residue 48, which is shared only with IRF-4, affects the ability of IRF-8\ICSBP to synergize and form an efficient heterocomplex with PU.1. Tyrosine residue 23, which is also conserved in IRF-4, IRF-5, and IRF-7, was not essential for the formation of heterocomplex with PU.1. These mutations of tyrosine residues in the DBD affect only the interaction with PU.1 and not that with IRF-1. These results support our published data demonstrating that the presence of target DNA is necessary for an efficient interaction of IRF-8\ICSBP with PU.1, but not with IRF-1 (7). In addition, tyrosine residues 110, within the DBD, and tyrosine residue 211, within the IAD, are conserved in all IRFs, and mutating it to phenylalanine leads to a defective IRF-8\ICSBP that does not interact effectively with either IRF-1/2 and PU.1 (D. Meraro and B. Z. Levi, unpublished observations) (39) . These results suggest that modulation of the phosphorylation state of some of the tyrosine residues in both the DBD and the IAD might have a role in the ability of the modified factor to form DNA heterocomplexes, thus affecting gene regulation. Accordingly, SHP1 protein tyrosine phosphatase inhibits the ability of IRF-8\ICSBP to interact with PU.1 and IRF-1, leading to reduced expression of the myeloidspecific genes CYBB (gp91 phox ) and NCF2 (p67 phox ) (39). The multicomplexes formed on the EIRE elements of CYBB and NCF2 are composed of PU.1, IRF-8\ICSBP, and IRF-1 and also recruit the cAMP response element binding protein (34) . The latter harbors histone acetyltransferase activity (40) . Here we show that the ISRE element of ISG15 recruits PU.1, IRF-8\ICSBP, IRF-4, and IRF-2. However, in all these studies the stoichiometry of the multisubunit complexes is not clear. In vitro studies showed that these EIRE can engage both IRFs heterocomplexes (e.g., IRF-8ICSBP/IRF-2 or IRF-8\ICSBP/IRF-1) and EtsIRFs heterocomplexes (e.g., PU.1/IRF-8\ICSBP or PU.1/IRF-4). EMSA performed with nuclear extracts prepared from U937 cells or Namalwa cells did not allow us to distinguish between these two options. When in vitro-translated proteins were reacted in EMSA it was clear that the interaction with the DNA was much stronger when PU.1, IRF-8ICSBP, and IRF-4 were incorporated (Fig. 3B,  lane 6 ). This suggests that such multicomplexes are formed through interaction between IADs located on both IRF-8\ICSBP and IRF-4 and PEST domains that were identified on PU.1, IRF-1, and IRF-2. Our results presented here demonstrate that both modules (IAD and PEST) were essential for association and transcriptional synergy. Recently, a direct role for IRF-8\ICSBP in the regulation of ISG15 was demonstrated in IRF-8\ICSBP knockout mice (28) . It was demonstrated that the heterocomplex formed between IRF-2, IRF-8ICSBP, and IRF-4 was detected in extracts from B cells, while a heterocomplex between IRF-4 and IRF-8\ICSBP was detected in cell extracts of macrophages. However, the presence of PU.1 in the heterocomplexes was not considered. In this communication we provide evidence showing that PU.1 is also a major component in the multicomplex formed on the ISRE of ISG15, which is essential for transcriptional activation.
In conclusion, our data indicate that EIREs are unique in their ability to recruit different factors in an assembled enhanceosomes. In nonimmune cells the factors will mainly include IRF members. In immune cells these EIRE elements will also recruit non-IRFs, such as PU.1, to the assembled enhanceosome. Thus, EIREs may affect the transcriptional capacity of different enhanceosomes in a cell type-restricted manner that is dependent upon the milieu of transcription factors. This leads to fine-tuning of the gene expression that is regulated in a spatial, temporal, and restricted manner. It is intriguing to speculate that myeloid cell genes that are specifically activated by IFN-␥ or inflammation are characterized by enhanceosomes with similar characteristics. In this context, the PEST domains of PU.1, IRF-1, and IRF-2 and the IADs of IRF-8ICSBP or IRF-4 may be used to bridge all these elements together to the proximity of the RNA polymerase II holoenzyme complex.
